Boston Scientific (BSX) reported 4.12billioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof14.50.62 for the same period compares to 0.53ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof4.02 billion, representing a surprise of +2.51%. The company delivered an EPS surprise of +6.90%, with the consensus EPS estimate being $0.58.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...